These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 15914111

  • 1. Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts.
    Di Napoli P, Taccardi AA, Grilli A, De Lutiis MA, Barsotti A, Felaco M, De Caterina R.
    Cardiovasc Res; 2005 Jun 01; 66(3):462-71. PubMed ID: 15914111
    [Abstract] [Full Text] [Related]

  • 2. Simvastatin reduces reperfusion injury by modulating nitric oxide synthase expression: an ex vivo study in isolated working rat hearts.
    Di Napoli P, Antonio Taccardi A, Grilli A, Spina R, Felaco M, Barsotti A, De Caterina R.
    Cardiovasc Res; 2001 Aug 01; 51(2):283-93. PubMed ID: 11470468
    [Abstract] [Full Text] [Related]

  • 3. [Simvastatin and ischemia-reperfusion damage: its effects on apoptotic myocyte death and on the endothelial expression of nitric-oxide synthetase in an experimental model of the isolated rat heart].
    Di Napoli P, Maggi A, Spina R, Barsotti L, Taccardi AA, Stuppia L, Vianale G, Palka G, Barsotti A.
    Cardiologia; 1999 Jan 01; 44(1):69-74. PubMed ID: 10188333
    [Abstract] [Full Text] [Related]

  • 4. Rosuvastatin preconditioning provides neuroprotection against spinal cord ischemia in rats through modulating nitric oxide synthase expressions.
    Die J, Wang K, Fan L, Jiang Y, Shi Z.
    Brain Res; 2010 Jul 30; 1346():251-61. PubMed ID: 20513366
    [Abstract] [Full Text] [Related]

  • 5. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
    Han H, Kaiser R, Hu K, Laser M, Ertl G, Bauersachs J.
    Basic Res Cardiol; 2003 May 30; 98(3):165-74. PubMed ID: 12883834
    [Abstract] [Full Text] [Related]

  • 6. Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2.
    Kilic U, Bassetti CL, Kilic E, Xing H, Wang Z, Hermann DM.
    Neuroscience; 2005 May 30; 134(3):901-6. PubMed ID: 16009498
    [Abstract] [Full Text] [Related]

  • 7. Oral pre-treatment with rosuvastatin protects porcine myocardium from ischaemia/reperfusion injury via a mechanism related to nitric oxide but not to serum cholesterol level.
    Bulhak AA, Gourine AV, Gonon AT, Sjöquist PO, Valen G, Pernow J.
    Acta Physiol Scand; 2005 Feb 30; 183(2):151-9. PubMed ID: 15676056
    [Abstract] [Full Text] [Related]

  • 8. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
    Kobara M, Tatsumi T, Takeda M, Mano A, Yamanaka S, Shiraishi J, Keira N, Matoba S, Asayama J, Nakagawa M.
    Basic Res Cardiol; 2003 Sep 30; 98(5):319-28. PubMed ID: 12955405
    [Abstract] [Full Text] [Related]

  • 9. [Effect of 17beta-estradiol on myocardial inducible NOS and endothelial NOS activities after ischemia-reperfusion in rat heart model].
    Wang XD, Wang ZM, Jia DL, Yu P.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 03; 87(25):1789-91. PubMed ID: 17919391
    [Abstract] [Full Text] [Related]

  • 10. Late protective effect of pharmacological preconditioning with total flavones of rhododendra against myocardial ischemia-reperfusion injury.
    Zhang JH, Chen ZW, Wu Z.
    Can J Physiol Pharmacol; 2008 Mar 03; 86(3):131-8. PubMed ID: 18418440
    [Abstract] [Full Text] [Related]

  • 11. MK-954 (losartan potassium) exerts endothelial protective effects against reperfusion injury: evidence of an e-NOS mRNA overexpression after global ischemia.
    Barsotti A, Di Napoli P, Taccardi AA, Spina R, Stuppia L, Palka G, Barbacane RC, De Caterina R, Conti P.
    Atherosclerosis; 2001 Mar 03; 155(1):53-9. PubMed ID: 11223426
    [Abstract] [Full Text] [Related]

  • 12. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart.
    Loucks EB, Godin DV, Walley KR, McManus BM, Rahimian R, Granville DJ, Hong JM, Aktary FM, Qayumi AK.
    Can J Cardiol; 2003 Mar 15; 19(3):267-74. PubMed ID: 12677282
    [Abstract] [Full Text] [Related]

  • 13. Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.
    Liuni A, Luca MC, Gori T, Parker JD.
    J Am Coll Cardiol; 2010 Mar 09; 55(10):1002-6. PubMed ID: 20202516
    [Abstract] [Full Text] [Related]

  • 14. Metabolic and functional protection by selective inhibition of nitric oxide synthase 2 during ischemia-reperfusion in isolated perfused hearts.
    Ramasamy R, Hwang YC, Liu Y, Son NH, Ma N, Parkinson J, Sciacca R, Albala A, Edwards N, Szabolcs MJ, Cannon PJ.
    Circulation; 2004 Apr 06; 109(13):1668-73. PubMed ID: 15051645
    [Abstract] [Full Text] [Related]

  • 15. Propofol improves cardiac functional recovery after ischemia-reperfusion by upregulating nitric oxide synthase activity in the isolated rat hearts.
    Sun HY, Xue FS, Xu YC, Li CW, Xiong J, Liao X, Zhang YM.
    Chin Med J (Engl); 2009 Dec 20; 122(24):3048-54. PubMed ID: 20137500
    [Abstract] [Full Text] [Related]

  • 16. Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbits.
    D'Annunzio V, Donato M, Erni L, Miksztowicz V, Buchholz B, Carrión CL, Schreier L, Wikinski R, Gelpi RJ, Berg G, Basso N.
    J Cardiovasc Pharmacol; 2009 Feb 20; 53(2):137-44. PubMed ID: 19188835
    [Abstract] [Full Text] [Related]

  • 17. Delayed 24 hours Nomega-nitro-L-arginine methyl ester injection induces pharmacological cardioprotection against reperfusion injury.
    Davani S, Vergely C, Royer B, Bouhaddi M, Reyssie H, Rochette L, Kantelip JP.
    Cell Mol Biol (Noisy-le-grand); 2007 Jan 21; 52 Suppl():OL868-73. PubMed ID: 17543224
    [Abstract] [Full Text] [Related]

  • 18. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F, Könemann S, Wolff B, Barth S, Staudt A, Kroemer HK, Dahm JB, Felix SB, Landsberger M.
    J Physiol Pharmacol; 2007 Sep 21; 58(3):503-14. PubMed ID: 17928646
    [Abstract] [Full Text] [Related]

  • 19. [Myocardial ischemic reperfusion injury affected by the isozymes of nitric oxide synthase and their gene expression: experimental study].
    Cui S, Zhu H.
    Zhonghua Yi Xue Za Zhi; 1998 May 21; 78(5):327-30. PubMed ID: 10923431
    [Abstract] [Full Text] [Related]

  • 20. Evidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Liu YN, Zhou ZM, Chen P.
    Clin Exp Pharmacol Physiol; 2008 Feb 21; 35(2):211-6. PubMed ID: 17941891
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.